David A. Siegel Codexis, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Codexis, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 99,500 shares of CDXS stock, worth $232,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,500
Previous 403,700
75.35%
Holding current value
$232,830
Previous $1.93 Million
86.13%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
63.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$22.2 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$19 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$11.1 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$7.02 Million1.17% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $153M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...